Τρίτη 8 Μαρτίου 2016

Low frequency of drug-resistant virus did not affect the therapeutic efficacy in daclatasvir plus asunaprevir therapy in patients with chronic HCV genotype-1 infection

Antiviral Therapy

from #Medicine via ola Kala on Inoreader http://ift.tt/21V7O8w
via IFTTT



from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1R2InGM
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου